Gary Jacob
Algemeen Directeur bij OKYO PHARMA LIMITED
Vermogen: 67 180 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Gary Jacob
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Oxford
260
| College/University | Other Consumer Services | 260 |
34
| Subsidiary | Wholesale Distributors | 34 |
| Public Company | Pharmaceuticals: Major | 22 | |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.
15
| Extinct | Pharmaceuticals: Major | 15 |
| Public Company | Biotechnology | 9 | |
G.D. Searle LLC
7
| Subsidiary | 7 | |
| Public Company | Pharmaceuticals: Major | 5 | |
| Public Company | Pharmaceuticals: Major | 4 | |
| Public Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gary Jacob via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Founder Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| TIZIANA LIFE SCIENCES LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| ACCUSTEM SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Director/Board Member Director of Finance/CFO | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member Director/Board Member Founder Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Doctorate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| SIGA TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman President Director/Board Member | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Pharmaceuticals: Other | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Alberta | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Director/Board Member Consultant / Advisor | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Founder Chairman | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
| CITIGROUP INC. | Major Banks | Compliance Officer Corporate Officer/Principal | |
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Pharmaceuticals: Major | Chairman President | |
| Lev Development Corp. | Chairman Chief Executive Officer | ||
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Graduate Degree | |
Prism Venture Management LLC
 Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| Seton Hall University | College/University | Undergraduate Degree Masters Business Admin | |
Opportunity@Work, Inc.
 Opportunity@Work, Inc. Miscellaneous Commercial ServicesCommercial Services Opportunity@Work, Inc. is engaged in providing techHire support services. The company was founded by Byron Auguste and Karan Chopra in 2015 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| Tufts University | College/University | Undergraduate Degree Graduate Degree | |
| MICROSOFT CORPORATION | Packaged Software | Director/Board Member Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Biotechnology | Director/Board Member Founder | |
| GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Axioma, Inc.
 Axioma, Inc. Packaged SoftwareTechnology Services Axioma, Inc. develops, markets, and implements optimization modeling and decision support software for the financial services industry. Its products include Axioma Portfolio Optimizer, Axioma Robust Risk Models, Axioma Performance Attribution, Axioma Backtester, Axioma Portfolio Analytics, and Axioma Risk Model Machine. The company was founded by Sebastián Ceria in 1998 and is headquartered in New York, NY. | Packaged Software | Chairman Director/Board Member | |
| AIRBNB, INC. | Other Consumer Services | Corporate Officer/Principal Director/Board Member | |
| Baruch S. Blumberg Institute | Corporate Officer/Principal Founder | ||
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Washington University in St. Louis | College/University | Director/Board Member Masters Business Admin | |
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| US Department of Health & Human Services (DC) | General Government | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Verenigd Koninkrijk | 6 |
| Canada | 5 |
| Bermuda | 3 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 6 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 479 |
| Corporate Officer/Principal | 206 |
| Independent Dir/Board Member | 122 |
| Chairman | 102 |
| Undergraduate Degree | 87 |
Sterkste connecties
| Insiders | |
|---|---|
| Richard Berman | 61 |
| Reid Hoffman | 53 |
| William Guttman | 42 |
| Tamar Howson | 41 |
| Koosum P. Kalyan | 34 |
| John Bell | 27 |
| James Sapirstein | 26 |
| Willy Simon | 24 |
| Gabriele Cerrone | 22 |
| Thomas H. Adams | 22 |
| Hugh Grant | 21 |
| Trevor D. Traina | 20 |
| Jonathan Hepple | 19 |
| Maria Teresa H. D. S. M. Roque Dal Fabbro | 18 |
| Joshua Lewis | 17 |
- Beurs
- Insiders
- Gary Jacob
- Bedrijfsconnecties
